327 related articles for article (PubMed ID: 34700192)
21. Gene signatures of quiescent glioblastoma cells reveal mesenchymal shift and interactions with niche microenvironment.
Tejero R; Huang Y; Katsyv I; Kluge M; Lin JY; Tome-Garcia J; Daviaud N; Wang Y; Zhang B; Tsankova NM; Friedel CC; Zou H; Friedel RH
EBioMedicine; 2019 Apr; 42():252-269. PubMed ID: 30952620
[TBL] [Abstract][Full Text] [Related]
22. Appendiceal Cancer Patient-Specific Tumor Organoid Model for Predicting Chemotherapy Efficacy Prior to Initiation of Treatment: A Feasibility Study.
Votanopoulos KI; Mazzocchi A; Sivakumar H; Forsythe S; Aleman J; Levine EA; Skardal A
Ann Surg Oncol; 2019 Jan; 26(1):139-147. PubMed ID: 30414038
[TBL] [Abstract][Full Text] [Related]
23. Translational models of 3-D organoids and cancer stem cells in gastric cancer research.
Wuputra K; Ku CC; Kato K; Wu DC; Saito S; Yokoyama KK
Stem Cell Res Ther; 2021 Sep; 12(1):492. PubMed ID: 34488885
[TBL] [Abstract][Full Text] [Related]
24. Organoid models of glioblastoma: advances, applications and challenges.
Zhang C; Jin M; Zhao J; Chen J; Jin W
Am J Cancer Res; 2020; 10(8):2242-2257. PubMed ID: 32905502
[TBL] [Abstract][Full Text] [Related]
25. Induction Therapy of Retinoic Acid with a Temozolomide-Loaded Gold Nanoparticle-Associated Ultrasound Effect on Glioblastoma Cancer Stem-Like Colonies.
Fadera S; Chen PY; Liu HL; Lee IC
ACS Appl Mater Interfaces; 2021 Jul; 13(28):32845-32855. PubMed ID: 34235925
[TBL] [Abstract][Full Text] [Related]
26. Establishment of 2.5D organoid culture model using 3D bladder cancer organoid culture.
Abugomaa A; Elbadawy M; Yamanaka M; Goto Y; Hayashi K; Mori T; Uchide T; Azakami D; Fukushima R; Yoshida T; Shibutani M; Yamashita R; Kobayashi M; Yamawaki H; Shinohara Y; Kaneda M; Usui T; Sasaki K
Sci Rep; 2020 Jun; 10(1):9393. PubMed ID: 32523078
[TBL] [Abstract][Full Text] [Related]
27. Three-Dimensional Organoids Reveal Therapy Resistance of Esophageal and Oropharyngeal Squamous Cell Carcinoma Cells.
Kijima T; Nakagawa H; Shimonosono M; Chandramouleeswaran PM; Hara T; Sahu V; Kasagi Y; Kikuchi O; Tanaka K; Giroux V; Muir AB; Whelan KA; Ohashi S; Naganuma S; Klein-Szanto AJ; Shinden Y; Sasaki K; Omoto I; Kita Y; Muto M; Bass AJ; Diehl JA; Ginsberg GG; Doki Y; Mori M; Uchikado Y; Arigami T; Avadhani NG; Basu D; Rustgi AK; Natsugoe S
Cell Mol Gastroenterol Hepatol; 2019; 7(1):73-91. PubMed ID: 30510992
[TBL] [Abstract][Full Text] [Related]
28. Establishment of patient-derived three-dimensional organoid culture in renal cell carcinoma.
Na JC; Kim JH; Kim SY; Gu YR; Jun DY; Lee HH; Yoon YE; Choi KH; Hong SJ; Han WK
Investig Clin Urol; 2020 Mar; 61(2):216-223. PubMed ID: 32158973
[TBL] [Abstract][Full Text] [Related]
29. Organoid Models of Glioblastoma and Their Role in Drug Discovery.
Rybin MJ; Ivan ME; Ayad NG; Zeier Z
Front Cell Neurosci; 2021; 15():605255. PubMed ID: 33613198
[TBL] [Abstract][Full Text] [Related]
30. Organoid Models of Glioblastoma to Study Brain Tumor Stem Cells.
Azzarelli R
Front Cell Dev Biol; 2020; 8():220. PubMed ID: 32373607
[TBL] [Abstract][Full Text] [Related]
31. Targeting cancer drug resistance utilizing organoid technology.
Chai C; Ji P; Xu H; Tang H; Wang Z; Zhang H; Zhou W
Biomed Pharmacother; 2023 Feb; 158():114098. PubMed ID: 36528918
[TBL] [Abstract][Full Text] [Related]
32. Patient-derived tumor organoid predicts drugs response in glioblastoma: A step forward in personalized cancer therapy?
Loong HH; Wong AM; Chan DT; Cheung MS; Chow C; Ding X; Chan AK; Johnston PA; Lau JY; Poon WS; Wong N
J Clin Neurosci; 2020 Aug; 78():400-402. PubMed ID: 32340843
[TBL] [Abstract][Full Text] [Related]
33. Organoid Cultures Derived From Patients With Papillary Thyroid Cancer.
Chen D; Tan Y; Li Z; Li W; Yu L; Chen W; Liu Y; Liu L; Guo L; Huang W; Zhao Y
J Clin Endocrinol Metab; 2021 Apr; 106(5):1410-1426. PubMed ID: 33524147
[TBL] [Abstract][Full Text] [Related]
34. A synopsis of prostate organoid methodologies, applications, and limitations.
Gleave AM; Ci X; Lin D; Wang Y
Prostate; 2020 May; 80(6):518-526. PubMed ID: 32084293
[TBL] [Abstract][Full Text] [Related]
35. Glioblastoma Organoids: Pre-Clinical Applications and Challenges in the Context of Immunotherapy.
Klein E; Hau AC; Oudin A; Golebiewska A; Niclou SP
Front Oncol; 2020; 10():604121. PubMed ID: 33364198
[TBL] [Abstract][Full Text] [Related]
36. Sox2, a stemness gene, regulates tumor-initiating and drug-resistant properties in CD133-positive glioblastoma stem cells.
Song WS; Yang YP; Huang CS; Lu KH; Liu WH; Wu WW; Lee YY; Lo WL; Lee SD; Chen YW; Huang PI; Chen MT
J Chin Med Assoc; 2016 Oct; 79(10):538-45. PubMed ID: 27530866
[TBL] [Abstract][Full Text] [Related]
37. Temozolomide-induced increase of tumorigenicity can be diminished by targeting of mitochondria in in vitro models of patient individual glioblastoma.
William D; Walther M; Schneider B; Linnebacher M; Classen CF
PLoS One; 2018; 13(1):e0191511. PubMed ID: 29352318
[TBL] [Abstract][Full Text] [Related]
38. Benchmarking pluripotent stem cell-derived organoid models.
De Los Angeles A; Tunbridge EM
Exp Neurol; 2020 Aug; 330():113333. PubMed ID: 32353463
[TBL] [Abstract][Full Text] [Related]
39. CEREBRAL ORGANOIDS AS A MODEL FOR GLIOBLASTOMA MULTIFORME.
Silvia N; Dai G
Curr Opin Biomed Eng; 2020 Mar; 13():152-159. PubMed ID: 32355905
[TBL] [Abstract][Full Text] [Related]
40. High-throughput deconvolution of 3D organoid dynamics at cellular resolution for cancer pharmacology with Cellos.
Mukashyaka P; Kumar P; Mellert DJ; Nicholas S; Noorbakhsh J; Brugiolo M; Courtois ET; Anczukow O; Liu ET; Chuang JH
Nat Commun; 2023 Dec; 14(1):8406. PubMed ID: 38114489
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
